Information Provided By: 
Fly News Breaks for May 18, 2018
SYN
May 18, 2018 | 07:07 EDT
H.C. Wainwright analyst Edward White started Synthetic Biologics with a Buy rating and $1 price target. The analyst says his target is based on the outlook of the company's pipeline, which contains ribaxamase, an oral biologic to protect the gut microbiome from IV betalactam antibiotics, that could cause clostridium difficile infection.
News For SYN From the Last 2 Days
There are no results for your query SYN
